{"id":"W2044083199","doi":"10.1016/s1470-2045(12)70013-x","title":"Don't pick the loser: lessons from the GeparQuinto trial","year":2012,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Taxane; Trastuzumab; Medicine; Lapatinib; Anthracycline; Oncology; Internal medicine; Epirubicin; Breast cancer; Docetaxel; Regimen; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01409445,0.0008941776,0.002455975,0.0005539284,0.002839842,0.005291401,0.002721871,0.04927311,0.0111227],"category_scores_gemma":[0.05465791,0.0005548034,0.001627173,0.0008802049,0.004214437,0.005671518,0.002494539,0.04390512,0.006522017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004045057,"about_ca_system_score_gemma":0.004637316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004068155,"about_ca_topic_score_gemma":0.009738334,"domain_scores_codex":[0.9913409,0.004541652,0.0004899017,0.0007898267,0.001885508,0.0009522677],"domain_scores_gemma":[0.9677844,0.02360709,0.001363605,0.000798011,0.001743728,0.004703207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007226285,0.00006323713,0.0006918645,0.0001595107,0.0001095545,0.0007649545,0.0001148205,0.0001493869,0.0002148858,0.007765985,0.9527448,0.03649842],"study_design_scores_gemma":[0.003309497,0.0004470926,0.002054367,0.001270696,0.000283452,0.001421044,0.000399867,0.0006429889,0.0004556256,0.06000848,0.9295627,0.0001441675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0005125563,0.005063939,0.00008704401,0.985489,0.005899879,0.000005565651,0.00009509946,0.00001846357,0.002828588],"genre_scores_gemma":[0.005382594,0.002641842,0.0001783637,0.9670282,0.0222916,0.0000268143,0.00004888057,0.00003937257,0.002362207],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.04927311,"threshold_uncertainty_score":0.07453948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.253008395605485,"score_gpt":0.4743445344544751,"score_spread":0.2213361388489901,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}